Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Kalantari

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Medicine|September 23, 2020
DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent mannerSepideh Razi, Asieh Sadeghi, Zeynab Asadi-Lari, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 20, 2014
Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomasZahra Madjd, Mohammad Esmaeil Akbari, Amir Hassan Zarnani, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 3, 2015
Chromogenic In Situ Hybridisation Test for Breast Cancer Patients with Equivocal IHC Results--a Study from IranMitra Mehrazma, Elham Kalantari, Hamid Rezvani, et al.
Experimental and Molecular Pathology|April 28, 2019
Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomasSomayeh Shafiei, Elham Kalantari, Leili Saeednejad Zanjani, et al.
Interdisciplinary Perspectives on Infectious Diseases|February 25, 2021
Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast IranSahar Sobhani, Reihaneh Aryan, Elham Kalantari, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2021
Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progressionLeili Saeednejad Zanjani, Mahdieh Razmi, Fahimeh Fattahi, et al.
Cancer Biomarkers : Section a of Disease Markers|December 27, 2021
Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancerElham Kalantari, Roya Ghods, Leili Saeednejad Zanjani, et al.
Parasitology Research|February 10, 2010
Application of recombinant Echinococcus granulosus antigen B to ELISA kits for diagnosing hydatidosisElham Kalantari, Mojgan Bandehpour, Ramin Pazoki, et al.
The Journal of Tehran Heart Center|December 14, 2016
Improvement of Heart Failure by Human Amniotic Mesenchymal Stromal Cell Transplantation in RatsSeyed Mohammad Taghi Razavi Tousi, Mahdieh Faghihi, Maliheh Nobakht, et al.
BMC Cancer|April 4, 2023
High expression of Talin-1 is associated with tumor progression and recurrence in melanoma skin cancer patientsYasaman Rezaie, Fahimeh Fattahi, Baharnaz Mashinchi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Medicine|September 23, 2020
DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent mannerSepideh Razi, Asieh Sadeghi, Zeynab Asadi-Lari, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 20, 2014
Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomasZahra Madjd, Mohammad Esmaeil Akbari, Amir Hassan Zarnani, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 3, 2015
Chromogenic In Situ Hybridisation Test for Breast Cancer Patients with Equivocal IHC Results--a Study from IranMitra Mehrazma, Elham Kalantari, Hamid Rezvani, et al.
Experimental and Molecular Pathology|April 28, 2019
Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomasSomayeh Shafiei, Elham Kalantari, Leili Saeednejad Zanjani, et al.
Interdisciplinary Perspectives on Infectious Diseases|February 25, 2021
Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients: A Report from Northeast IranSahar Sobhani, Reihaneh Aryan, Elham Kalantari, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2021
Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progressionLeili Saeednejad Zanjani, Mahdieh Razmi, Fahimeh Fattahi, et al.
Cancer Biomarkers : Section a of Disease Markers|December 27, 2021
Cytoplasmic expression of DCLK1-S, a novel DCLK1 isoform, is associated with tumor aggressiveness and worse disease-specific survival in colorectal cancerElham Kalantari, Roya Ghods, Leili Saeednejad Zanjani, et al.
Parasitology Research|February 10, 2010
Application of recombinant Echinococcus granulosus antigen B to ELISA kits for diagnosing hydatidosisElham Kalantari, Mojgan Bandehpour, Ramin Pazoki, et al.
The Journal of Tehran Heart Center|December 14, 2016
Improvement of Heart Failure by Human Amniotic Mesenchymal Stromal Cell Transplantation in RatsSeyed Mohammad Taghi Razavi Tousi, Mahdieh Faghihi, Maliheh Nobakht, et al.
BMC Cancer|April 4, 2023
High expression of Talin-1 is associated with tumor progression and recurrence in melanoma skin cancer patientsYasaman Rezaie, Fahimeh Fattahi, Baharnaz Mashinchi, et al.
Pageof 4